<DOC>
	<DOCNO>NCT02395315</DOCNO>
	<brief_summary>Type 2 Diabetes Mellitus ( DM ) prevalent metabolic disorder adult population affect roughly 17.7 million people US alone . The harmful effect DM implant integration survival attribute vascular complication alveolar bone lead compromise blood supply decrease bone density . Nonetheless , specific detrimental effect DM alveolar bone investigated human . People DM generally lose teeth person without diabetes , implant placement well control diabetic routinely perform due lack relevant evidence risk implant failure associate complication . Chemically modify , micro-rough , hydrophilic ( SLActive® ) titanium implant surface show accelerate osseointegration dental implant place diabetic animal . It hypothesize enhanced biologic response due biocompatibility hydrophilicity surface actively attract blood populate progenitor cell , growth factor improve stromal cell differentiation . Hypotheses : It hypothesize hyperglycemia result compromise vascularity mandible . Thus , hydrophilic TiZr implant surface ( Roxolid® ) actively attract fluid possess excellent osteoconductive property , may enhance peri-implant bone response diabetic patient level comparable well-controlled diabetic .</brief_summary>
	<brief_title>Alveolar Bone Changes Diabetes ( ABCD ) Study</brief_title>
	<detailed_description>A high level evidence exist support placement implant type 2 diabetic glucosylated hemoglobin ( HbA1c ) level within normoglycemic range . Less information available integration implant place diabetic achieve good glycemic control , may represent 50 % diabetic patient population . Recent data medical literature unveil deleterious effect uncontrolled diabetes mellitus ( DM ) bone marrow . The microvascular alteration DM skeletal bone lead microangiopathy , reduce blood flow fatty degeneration bone marrow . Nascent theory found upon observation increase level soluble osteoprotegerin ( OPG ) level uncontrolled DM implicate disruption RANKL/OPG signal potential pathway diabetes- related bone alteration . Nonetheless , data currently available pathophysiology alveolar bone patient DM . It hypothesize 1 ) hyperglycemia result compromise vascularity mandible , thus 2 ) hydrophilic TiZr implant surface ( Roxolid® ) actively attract fluid possess excellent osteoconductive property , may enhance peri-implant bone response well-controlled diabetic ( NCD ) level comparable well-controlled diabetic ( WCD ) . We hypothesize expect decreased RANKL/OPG ratio NCD versus WCD recover post-surgery bone remodel . To assess hypothesis , recruit n=21 type II WCD ( HbA1c≤7.0 % ) n=21 type II NCD ( 7.5 % &lt; HbA1c≤10 % ) seek implant placement mandible . We collect intra-operative bone specimen baseline blood sample ass bone structural alteration ( H &amp; E stain ) , microvascular density ( immunohistochemistry ) , bind RANKL/OPG ( immunohistochemistry ) serum RANKL/OPG ( ELISA ) . Implant integration success assess 3 , 6 , 12 36-months . Obtained result give dental researcher new insight pathophysiology alveolar bone diabetes provide information safety efficacy implant placement type II diabetic patient control glycemic status . Collectively , work pave way identify efficacious implant treatment modality person live type II diabetes alleviate morbidity associate tooth loss susceptible population group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Adult patient age 1885 year diagnose DM2 . History DM2 least two year prior enrollment . At least one edentulous site canine posterior mandible region . HbA1c &gt; 7.5 % &amp; &lt; 10 % enrollment test group . HbA1c ≤ 7.0 % enrollment control group . Available follow 12 month . Mandibular incisor site allow bone core retrieval due limit alveolar bone width ( ridge width &lt; 5mm , height &lt; 10mm ) confirm preoperative CBCT . Smokers : current , exsmokers &lt; 2 year cessation . Active periodontal disease . Medications affect bone healing ( e.g . bisphosphonates chronic steroid ) . Patients carrier transmissible disease ( ) may unnecessarily expose laboratory personnel risk . Participants physiciandiagnosed osteoporosis ( Zscore ≤ 2 ) . Females pregnancy lactation females plan become pregnant following year . Patients agree participate study sign consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Osseointegration</keyword>
	<keyword>Bone vascularity</keyword>
	<keyword>Primary implant stability</keyword>
</DOC>